Steven L. Roberds

8.5k citations

49 papers · 3.6k indexed · 1 hit paper · h-index 25

Molecular Biology top 2%
Cellular and Molecular Neuroscience top 2%
Physiology top 2%
Cardiology and Cardiovascular Medicine top 2%
Cell Biology top 2%

Co-authors: Kevin P. Campbell Michael M. Tamkun Richard H. Scheller Richard D. Anderson John P. Merlie Oxana Ibraghimov‐Beskrovnaya Elizabeth D. Apel Dirk J. Snyders
Topics: Muscle Physiology and Disorders (18 papers)Ion channel regulation and function (8 papers)Tuberous Sclerosis Complex Research (7 papers)
Cited by: Cellular and Molecular Neuroscience Molecular Biology Cardiology and Cardiovascular Medicine
Journals: Cell Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United States Sweden France

In The Last Decade

Steven L. Roberds

47 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics

2001 557 citations Steven L. Roberds Human Molecular Genetics profile →

Peers

Countries citing papers authored by Steven L. Roberds

Since Specialization

Citations

This map shows the geographic impact of Steven L. Roberds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven L. Roberds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven L. Roberds more than expected).

Fields of papers citing papers by Steven L. Roberds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven L. Roberds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven L. Roberds. The network helps show where Steven L. Roberds may publish in the future.

Co-authorship network of co-authors of Steven L. Roberds

This figure shows the co-authorship network connecting the top 25 collaborators of Steven L. Roberds. A scholar is included among the top collaborators of Steven L. Roberds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven L. Roberds. Steven L. Roberds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cutaneous manifestations-associated with tuberous sclerosis complex and the use of topical rapamycin in the United States: a sub-analysis of an international survey of caregivers and patients 2025 ·Orphanet Journal of Rare Diseases ·(unknown),(unknown),(unknown),Steven L. Roberds,(unknown)	0
2	The role of the TSC Alliance in advancing therapy development: a patient organization perspective 2024 ·PubMed ·Steven L. Roberds,Zoë Fuchs,(unknown),(unknown),(unknown),(unknown),Dean J. Aguiar	0
3	Inhibition of MEK-ERK signaling reduces seizures in two mouse models of tuberous sclerosis complex 2022 ·Epilepsy Research ·Lena H. Nguyen,Steven C. Leiser,Dekun Song,Daniela Brunner,Steven L. Roberds,Michael Wong,Angélique Bordey	16
4	Epilepsy Community at an Inflection Point: Translating Research Toward Curing the Epilepsies and Improving Patient Outcomes 2021 ·Epiliepsy currents ·(unknown),(unknown),Brandy Fureman,Mary Anne Meskis,Steven L. Roberds,(unknown),Heidi L. Grabenstatter,Vanessa Vogel‐Farley,Laura S. Lubbers	2
5	Approach to Preventive Epilepsy Treatment in Tuberous Sclerosis Complex and Current Clinical Practice in 23 Countries 2020 ·Pediatric Neurology ·(unknown),Katarzyna Kotulska,Sylwia Szymańska,Steven L. Roberds,Carla Fladrowski,Sergiusz Jóźwiak	17
6	Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex 2020 ·Neuropharmacology ·Wiebke Theilmann,Birthe Gericke,(unknown),Syed Muhammad Muneeb Anjum,(unknown),(unknown),Steven L. Roberds,Dean J. Aguiar,Daniela Brunner,Steven C. Leiser,Dekun Song,Doriano Fabbro,Petra Hillmann,Matthias P. Wymann,Wolfgang Löscher	23
7	The Impact of Psychiatric Symptoms on Tuberous Sclerosis Complex and Utilization of Mental Health Treatment 2018 ·Pediatric Neurology ·Kate Mowrey,(unknown),Deborah A. Pearson,S. Shahrukh Hashmi,Steven L. Roberds,Laura S. Farach,Hope Northrup	6
8	Exploring the foundation of genomics: a Northern blot reference set for the comparative analysis of transcript profiling technologies 2004 ·Comparative and Functional Genomics ·(unknown),(unknown),Emily Hodges,Jonathan Lim,(unknown),(unknown),Anders Lundmark,(unknown),Raf M. Podowski,Erik L. L. Sonnhammer,Peter Nilsson,Mark Reimers,Boris Lenhard,Steven L. Roberds,Claes Wahlestedt,Christer Höög,Pankaj Agarwal,Wyeth W. Wasserman	1
9	A cluster of novel serotonin receptor 3-like genes on human chromosome 3 2003 ·Gene ·Alla Karnovsky,(unknown),Denise D. McKinley,(unknown),Cara Ruble,(unknown),(unknown),Jerry L. Slightom,Laura R. Fitzgerald,C W Benjamin,Steven L. Roberds	69
10	Characterization and Expression of Nicotinic ACh Receptors in the Mammalian Retina 2002 ·Investigative Ophthalmology & Visual Science ·(unknown),(unknown),(unknown),(unknown),Martin Aastrup Olsen,Steven L. Roberds,(unknown)	3
11	BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeuticsbreakdown → 2001 ·Human Molecular Genetics ·Steven L. Roberds	557
12	A 5′ Dystrophin Duplication Mutation Causes Membrane Deficiency of -Dystroglycan in a Family with X-linked Cardiomyopathy 1997 ·Journal of Molecular and Cellular Cardiology ·Roger D. Bies,Masato Maeda,Steven L. Roberds,Emma Holder,Teresa Bohlmeyer,James B. Young,Kevin P. Campbell	46
13	CLINICAL AND MOLECULAR PATHOLOGICAL FEATURES OF SEVERE CHILDHOOD AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY IN SAUDI ARABIA 1996 ·Developmental Medicine & Child Neurology ·Mustafa A. Salih,(unknown),(unknown),(unknown),Steven L. Roberds,Richard D. Anderson,Kevin P. Campbell	11
14	Expression of Deletion-Containing Dystrophins in mdx Muscle: Implications for Gene Therapy and Dystrophin Function 1995 ·Pediatric Research ·Jeffery D. Fritz,István Dankó,Steven L. Roberds,Kevin P. Campbell,(unknown),Jon A. Wolff	12
15	A common missense mutation in the adhalin gene in three unrelated Brazilian families with a relatively mild form of autosomal recessive limb-girdle muscular dystrophy 1995 ·Human Molecular Genetics ·(unknown),Eloísa S. Moreira,Mariz Vainzof,Jeffrey S. Chamberlain,(unknown),Leandro de Mattos Pereira,Jennifer A. Akiyama,Steven L. Roberds,Kevin P. Campbell,Mayana Zatz	57
16	α‐Dystroglycan deficiency correlates with elevated serum creatine kinase and decreased muscle contraction tension in golden retriever muscular dystrophy 1994 ·FEBS Letters ·James M. Ervasti,Steven L. Roberds,Richard D. Anderson,Nicholas Sharp,Joe N. Kornegay,Kevin P. Campbell	12
17	Abnormal expression of laminin suggests disturbance of sarcolemma-extracellular matrix interaction in Japanese patients with autosomal recessive muscular dystrophy deficient in adhalin. 1994 ·Journal of Clinical Investigation ·I. Higuchi,Hirotsugu Yamada,Hidetoshi Fukunaga,Hiroyuki Iwaki,(unknown),M. Nakagawa,Mitsuhiro Osame,Steven L. Roberds,T. Shimizu,Kevin P. Campbell	27
18	Molecular Biology of the Voltage‐Gated Potassium Channels of the Cardiovascular System 1993 ·Journal of Cardiovascular Electrophysiology ·Steven L. Roberds,(unknown),Sunny S. Po,Thomas A. Blair,Paul B. Bennett,R P Hartshorne,Dirk J. Snyders,Michael M. Tamkun	56
19	Functional characterization of RK5, a voltage‐gated K⁺ channel cloned from the rat cardiovascular system 1991 ·FEBS Letters ·Thomas A. Blair,Steven L. Roberds,(unknown),R P Hartshorne	54
20	Highly degenerate, inosine-containing primers specifically amplify rare cDNA using the polymerase chain reaction 1988 ·Nucleic Acids Research ·K Knoth,Steven L. Roberds,(unknown),(unknown)	89

About Steven L. Roberds

Steven L. Roberds is a scholar working on Genetics, Biochemistry and Physiology, having authored 49 papers that have together received 3.6k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (18 papers), Ion channel regulation and function (8 papers) and Tuberous Sclerosis Complex Research (7 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.1k citations), Molecular Biology (2.7k citations) and Cardiology and Cardiovascular Medicine (862 citations). Steven L. Roberds has collaborated with scholars based in United States, Sweden and France. Frequent co-authors include Kevin P. Campbell, Michael M. Tamkun, Richard H. Scheller, Richard D. Anderson, John P. Merlie, Oxana Ibraghimov‐Beskrovnaya, Elizabeth D. Apel, Dirk J. Snyders, Paul B. Bennett and Sunny S. Po. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact